Paolo Tarantino, MD, PhD, is a Medical Oncologist and Clinical Fellow at Dana-Farber Cancer Institute affiliated with Harvard. He specializes in breast oncology, HER2, and antibody-drug conjugates, and serves as Social Media Editor for ESMO Open. Dr. Tarantino is actively involved in clinical research and precision oncology, contributing thought leadership in cancer management.

‌